---
figid: PMC8986139__CAM4-11-1589-g011
pmcid: PMC8986139
image_filename: CAM4-11-1589-g011.jpg
figure_link: /pmc/articles/PMC8986139/figure/cam44509-fig-0003/
number: FIGURE 3
figure_title: ''
caption: RNASEH1‐AS1 affects NSCLC cell metastasis and ETM. (A, B) NSCLC cell motility
  after the downregulation or upregulation of RNASEH1‐AS1 expression (×200 magnification).
  (C) The expression of N‐cadherin, Vimentin, and E‐cadherin in NSCLC cells after
  the downregulation or upregulation of RNASEH1‐AS1. **p<0.01
article_title: Long noncoding RNASEH1‐AS1 exacerbates the progression of non‐small
  cell lung cancer by acting as a ceRNA to regulate microRNA‐516a‐5p/FOXK1 and thereby
  activating the Wnt/β‐catenin signaling pathway.
citation: Chan Zhang, et al. Cancer Med. 2022 Apr;11(7):1589-1604.
year: '2022'

doi: 10.1002/cam4.4509
journal_title: Cancer Medicine
journal_nlm_ta: Cancer Med
publisher_name: John Wiley and Sons Inc.

keywords:
- ceRNA network
- epithelial‐mesenchymal transition
- RNASEH1 antisense RNA 1
- Wnt/β‐catenin pathway

---
